In mice with hepatic mitoribosomal defect, FGF21 was shown to specifically ameliorate glucose clearance, energy expenditure, and thermogenesis, while GDF15 was differentially beneficial for fat mass and hepatic steatosis (Kang, Choi, et al., 2021). The gene discussed is GDF15; the disease is Hepatic steatosis.